Literature DB >> 1576492

Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970.

J A Akoh1, I M Macintyre.   

Abstract

In this review of English language publications from 1970, 5-year survival rates after surgery for gastric cancer have been analysed. While the proportion of patients coming to operation has fallen from 92 per cent before 1970 to 71 per cent by 1990, the proportion of operated patients undergoing resection has increased from 37 per cent before 1970 to 48 per cent before 1990. This change suggests improved preoperative staging leading to better patient selection for operation. The 5-year survival rate following all resections has increased significantly from 20.7 per cent before 1970 to 28.4 per cent before 1990, an increase of 7.7 per cent (95 per cent confidence interval 7.1-8.3 per cent). The 5-year survival rate following curative or radical resection has risen from 37.6 to 55.4 per cent over the same period, an increase of 17.8 per cent (95 per cent confidence interval 17.1-18.5 per cent). It is likely that this improvement has contributed to the decrease in the mortality rate from gastric cancer. Comparison of Japanese series with others suggests that diagnosis and treatment of the disease at an earlier stage will result in an even greater increase in 5-year survival rates outside Japan. Of the papers studied, 56 per cent were excluded from analysis, the majority because the data provided about 5-year survival rates were insufficient or the survival calculations inappropriate. Results of survival after operations for gastric cancer should be calculated and presented in a standardized manner.

Entities:  

Mesh:

Year:  1992        PMID: 1576492     DOI: 10.1002/bjs.1800790404

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  42 in total

1.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Etiologic and Clinicopathological Correlates of Gastric Carcinoma in the Egyptian Delta.

Authors:  Mohamed Farouk Akl; Mohamed Awad Ibrahem; Ashraf Khater; Eman El-Zahaf; Kamel Farag; Heba Abdallah
Journal:  Indian J Surg Oncol       Date:  2018-05-23

3.  Identification of prognosis-related proteins in advanced gastric cancer by mass spectrometry-based comparative proteomics.

Authors:  Shu-Qin Jia; Zhao-Jian Niu; Lian-Hai Zhang; Xi-Yao Zhong; Tao Shi; Hong Du; Gui-Guo Zhang; Ying Hu; Xiu-Lan Su; Jia-Fu Ji
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-01       Impact factor: 4.553

4.  Survival in stomach cancer is improving: results of a nationwide population-based Swedish study.

Authors:  L E Hansson; P Sparén; O Nyrén
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

Review 5.  Lymphadenectomy for gastric cancer in clinical trials: update.

Authors:  J D Roder; J J Bonenkamp; J Craven; C J van de Velde; M Sasako; K Böttcher; H J Stein
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

6.  Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study.

Authors:  Thomas Makatsoris; Pavlos Papakostas; Haralabos P Kalofonos; Ioannis Xanthakis; Dimitrios Tsavdaridis; Gerasimos Aravantinos; Helen Gogas; George Klouvas; Paris Kosmidis; Dimitrios Pectasides; George Fountzilas
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

7.  The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites.

Authors:  Minkyu Jung; Hei-Cheul Jeung; Sung Sook Lee; Jun Yong Park; Soojung Hong; Soo Hyeon Lee; Sung Hoon Noh; Hyun Cheol Chung; Sun Young Rha
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-23       Impact factor: 4.553

8.  Characteristics of synchronous cancers in gastric cancer patients.

Authors:  Ja Seong Bae; Jun Ho Lee; Keun Won Ryu; Young Woo Kim; Jae Moon Bae
Journal:  Cancer Res Treat       Date:  2006-02-28       Impact factor: 4.679

9.  L-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients' survival with stomach adenocarcinomas.

Authors:  Dimitra Florou; Iordanis N Papadopoulos; Emmanuel G Fragoulis; Andreas Scorilas
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-12       Impact factor: 4.553

10.  Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer.

Authors:  Antonios-Apostolos K Tentes; Sotirios K Markakidis; Charisios Karanikiotis; Aliki Fiska; Ioannis K Tentes; Vangelis G Manolopoulos; Thespis Dimitriou
Journal:  Langenbecks Arch Surg       Date:  2006-03-14       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.